Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01779973 · ClinicalTrials.gov registry record · NA
Remote Observed Dosing to Increase Suboxone Compliance
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT01779973: Completed NA study, sponsored by University of Pennsylvania.
NCT01779973 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01779973, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The goal of this project is to test the feasibility, acceptability, and preliminary efficacy of using remote compliance monitoring in buprenorphine (Suboxone®) treatment for opiate dependence. To that end, 10 opiate dependent subjects will be recruited through the University of Pennsylvania's Treatment Research Center, an outpatient substance abuse treatment facility. All subjects will receive buprenorphine (Suboxone®) (16 mg/day, adjusted as needed according to individual requirements).
Interventions
- BEHAVIORAL Remote Observed Dosing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2013-02 |
| Est. Completion | 2013-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01779973
The ClinicalTrials.gov registry entry for NCT01779973 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Remote Observed Dosing is the first listed.
NCT01779973 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01779973 about?
NCT01779973 is a clinical study titled "Remote Observed Dosing to Increase Suboxone Compliance". The goal of this project is to test the feasibility, acceptability, and preliminary efficacy of using remote compliance monitoring in buprenorphine (Suboxone®) treatment for opiate dependence. To that end, 10 opiate dependent subjects will be recruited through the University of Pennsylvania's Treatm...
What is the current status of trial NCT01779973?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2013-02. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01779973?
The interventions under investigation include: Remote Observed Dosing (BEHAVIORAL).
Who is sponsoring clinical trial NCT01779973?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.